Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

3.995 -0.075 (-1.84%)
Streaming Delayed Price Updated: 3:38 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,464,661
Open 4.040
Bid (Size) 3.990 (101)
Ask (Size) 4.000 (40)
Prev. Close 4.070
Today's Range 3.960 - 4.080
52wk Range 3.812 - 29.30
Shares Outstanding 92,200,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Small-Cap Stocks with Questionable Fundamentals
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
This UnitedHealth Group Analyst Turns Bearish; Here Are Top 3 Downgrades For Wednesday
Via Benzinga

Performance

YTD
-70.4%
-70.4%
1 Month
-46.0%
-46.0%
3 Month
-73.2%
-73.2%
6 Month
-73.9%
-73.9%
1 Year
-83.6%
-83.6%

More News

Read More
CI&T, Novavax, Paramount Group And Other Big Stocks Moving Higher On Monday
Via Benzinga
MYGN Q1 Earnings Call: Guidance Cut Amid GeneSight Challenges and Slow Hereditary Cancer Ramp
Via StockStory
Earnings Scheduled For May 6, 2025
Via Benzinga
Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
From Myriad Genetics, Inc.
Via GlobeNewswire
3 of Wall Street’s Favorite Stocks in Dangerous Territory
Via StockStory
Securities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Myriad Genetics, Inc. (MYGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Myriad Genetics Shares Tank 41% On Analyst Downgrades, Weaker Guidance: Yet Retail Investors Remain Bullish
Via Stocktwits
Securities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
What Analysts Are Saying About Myriad Genetics Stock
Via Benzinga
Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
From Myriad Genetics, Inc.
Via GlobeNewswire
Top movers in Wednesday's session
Via Chartmill
Why Myriad Genetics (MYGN) Stock Is Down Today
Via StockStory
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Falls 1%; Uber Sales Miss Estimates
Via Benzinga
Topics Earnings
Exposures Financial Fossil Fuels
Wednesday's session: top gainers and losers
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Myriad Genetics (NASDAQ:MYGN) Misses Q1 Sales Targets, Stock Drops 14.5%
Via StockStory
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Which stocks are moving after the closing bell on Tuesday?
Via Chartmill
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
From Myriad Genetics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 3.995
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 05/22/25 03:38 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 368.34M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 368M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.